Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05215782 · ClinicalTrials.gov registry record
Eye to Brain Connection
A clinical trial of Alzheimer Disease, sponsored by Optina Diagnostics.
- Completed
- Registry status
- 65
- Enrollment target
- 1
- Study location
NCT05215782 is a study of Alzheimer Disease that has completed, run by Optina Diagnostics. The registered enrollment target is 65 participants, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05215782, a study of Alzheimer Disease, has completed, sponsored by Optina Diagnostics.
- COMPLETED
- Registry status
- 65 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a non-randomized, non-treatment, observational study designed to discover correlations between retinal imaging and amyloid PET imaging. Subjects will be recruited to the clinical cohort from referring physicians. Subjects may be participants from existing studies and clinical practices
Conditions Studied
Study Locations (1)
Florida
- Ezy medical research - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2022-03-14 |
| Est. Completion | 2023-03-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05215782
The ClinicalTrials.gov registry entry for NCT05215782 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (98% lower). The listed sponsor is Optina Diagnostics, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Alzheimer Disease appearing as the primary indexed condition, and to 0 interventions.
NCT05215782 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT05215782 about?
NCT05215782 is a clinical study titled "Eye to Brain Connection". This is a non-randomized, non-treatment, observational study designed to discover correlations between retinal imaging and amyloid PET imaging. Subjects will be recruited to the clinical cohort from referring physicians. Subjects may be participants from existing studies and clinical practices
What is the current status of trial NCT05215782?
This trial is currently completed. The enrollment target is 65 participants. The study started on 2022-03-14. Estimated completion is 2023-03-16.
What conditions does trial NCT05215782 study?
This clinical trial studies the following conditions: Alzheimer Disease.
Who is sponsoring clinical trial NCT05215782?
This trial is sponsored by Optina Diagnostics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05215782 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2)
RECRUITING · Phase 3
-
Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease
RECRUITING · Phase 4
-
Systemic and Central Inflammation in AD
RECRUITING · Phase 2
-
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
RECRUITING · NA
-
Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheimer's Disease
RECRUITING · Phase 1
-
Cognitive Neurology Unit Clinical Registry
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.